IDiyas

For the Inventor, By the Inventor

Doylestown, PA, United States of America

Catherine P Prouty

USPTO Granted Patents = 25

 

Average Co-Inventor Count = 5.0

ph-index = 7

Forward Citations = 142(Granted Patents)


Location History:

  • Wayne, PA (US) (1995 - 1996)
  • Doylestown, PA (US) (1997 - 2017)
  • San Diego, CA (US) (2018)

Company Filing History:

goldMedal7 out of 363 
 
Ortho-mcneil Pharmaceutical Corp.
 patents
silverMedal5 out of 1,149 
 
Vertex Pharmaceuticals, Inc.
 patents
bronzeMedal5 out of 25 
 
Ignyta, Inc.
 patents
4. 3 out of 2,076 
 
Janssen Pharmaceutica Nv
 patents
5. 2 out of 206 
 
Sterling Winthrop Inc.
 patents
6. 2 out of 247 
 
Cephalon, Inc.
 patents
7. 1 out of 1 
 
Sanoft
 patent

Years Active: 1995-2018

Loading Chart...
Loading Chart...
25 patents (USPTO):Explore Patents
1. 10017496 - Uracil derivatives as AXL and c-MET kinase inhibitors (2018-07-10),
2. 9745283 - Uracil derivatives as AXL and c-MET kinase inhibitors (2017-08-29),
3. 9522902 - Uracil derivatives as AXL and c-MET kinase inhibitors (2016-12-20),
4. 9120778 - Uracil derivatives as AXL and c-MET kinase inhibitors (2015-09-01),
5. 9029538 - Uracil derivatives as AXL and c-MET kinase inhibitors (2015-05-12),
6. 8912183 - Substituted pyridazine derivatives (2014-12-16),
7. 8076331 - Substituted pyridazine derivatives (2011-12-13),
8. 8012963 - 3,4-dihydro-2H-benzo[1,4]oxazine and thiazine derivatives as CETP inhibitors (2011-09-06),
9. 7749995 - 3,4-dihydro-2h-benzo[1,4]oxazine and thiazine derivatives as CETP inhibitors (2010-07-06),
10. 6841682 - Heterocycles useful in the treatment of benign prostatic hyperplasia (2005-01-11),
11. 6828327 - Macroheterocylic compounds useful as kinase inhibitors (2004-12-07),
12. 6780994 - Phthalimido arylpiperazines useful in the treatment of benign prostatic hyperplasia (2004-08-24),
13. 6710048 - Pyrazine derivatives as modulators of tyrosine kinases (2004-03-23),
14. 6576614 - Peptide analogs as irreversible interleukin-1&bgr; protease inhibitors (2003-06-10),
15. 6407080 - N-(pyrimidinyl)-aspartic acid analogs as interleukin-1&bgr; converting enzyme inhibitors (2002-06-18),

Title: The Innovative Contributions of Catherine P Prouty

Introduction

Catherine P Prouty is a distinguished inventor based in Doylestown, PA (US), known for her significant contributions to the field of pharmaceuticals. With a remarkable portfolio of 25 patents, she has played a vital role in advancing medical research and treatment methodologies.

Latest Patents

Among Prouty's most recent inventions are her patents regarding Uracil derivatives as AXL and c-MET kinase inhibitors. These patents detail the development of novel compounds of Formula I, along with their pharmaceutically acceptable salt forms. Her work focuses on innovative methods of treatment and applications that could have a profound impact on patient care.

Career Highlights

Catherine has made substantial contributions during her tenure at notable companies such as Ortho-McNeil Pharmaceutical Corporation and Vertex Pharmaceuticals, Inc. Her expertise in pharmaceutical research has helped shape advancements in drug development and therapeutic interventions.

Collaborations

Throughout her career, Prouty has collaborated with distinguished colleagues, including Gee-Hong Kuo and Roland Ellwood Dolle. These partnerships have fostered a rich environment for innovation, leading to groundbreaking inventions and patents.

Conclusion

Catherine P Prouty stands out as a notable inventor whose contributions have significantly influenced the pharmaceutical landscape. Her extensive work on Uracil derivatives as kinase inhibitors exemplifies her commitment to advancing medical science and improving treatment options for patients. As an inventor, her legacy continues to inspire future generations of researchers and innovators.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…